PFM Health Sciences’s Honeywell HON Stock Holding History

PFM Health Sciences’s Portfolio HON Stock Details HON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-198,805	Closed	-$20.8M	–	107
2016 Q4	$20.8M	Buy	+198,805	New	+$20.2M	0.59%	56

Other funds holding HON

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ETC

Evercore Trust Company New York $34.6B AUM 25.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PFM Health Sciences's HON Position: Q1 2017 in Review

PFM Health Sciences sold out of Honeywell (HON) in Q1 2017, closing a stake of 198,805 shares — an estimated $20.8M sold.

PFM Health Sciences first reported a position in HON in Q4 2016 and held it in 1 quarter. The position peaked at $20.8M in Q4 2016. 1,473 funds tracked by Wall St. Rank hold HON as of Q1 2017.

PFM Health Sciences reported no remaining Honeywell position as of Q1 2017 after selling out during the quarter.
PFM Health Sciences sold 198,805 Honeywell shares in Q1 2017, an estimated $20.8M.
PFM Health Sciences first reported a position in Honeywell in Q4 2016 and held it in 1 quarter.
PFM Health Sciences's Honeywell position peaked at $20.8M in Q4 2016.
1,473 funds tracked by Wall St. Rank held Honeywell as of Q1 2017.

Based on PFM Health Sciences's 13F filing for Q1 2017, filed 15 May 2017.